- Home
- BBIO vs FICO Comparison
BBIO vs FICO Comparison
Compare BBIO & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FICO
- Stock Information
- Founded
- BBIO 2015
- FICO 1956
- Country
- BBIO United States
- FICO United States
- Employees
- BBIO N/A
- FICO N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FICO Business Services
- Sector
- BBIO Health Care
- FICO Consumer Discretionary
- Exchange
- BBIO Nasdaq
- FICO Nasdaq
- Market Cap
- BBIO 9.4B
- FICO 32.2B
- IPO Year
- BBIO 2019
- FICO 1987
- Fundamental
- Price
- BBIO $51.18
- FICO $1,552.59
- Analyst Decision
- BBIO Strong Buy
- FICO Buy
- Analyst Count
- BBIO 16
- FICO 12
- Target Price
- BBIO $64.44
- FICO $2,068.67
- AVG Volume (30 Days)
- BBIO 2.1M
- FICO 308.9K
- Earning Date
- BBIO 11-11-2025
- FICO 11-05-2025
- Dividend Yield
- BBIO N/A
- FICO N/A
- EPS Growth
- BBIO N/A
- FICO 34.32
- EPS
- BBIO N/A
- FICO 25.55
- Revenue
- BBIO $235,812,000.00
- FICO $1,928,927,000.00
- Revenue This Year
- BBIO $115.97
- FICO $18.02
- Revenue Next Year
- BBIO $65.50
- FICO $13.91
- P/E Ratio
- BBIO N/A
- FICO $60.72
- Revenue Growth
- BBIO 7.62
- FICO 16.66
- 52 Week Low
- BBIO $21.72
- FICO $1,300.00
- 52 Week High
- BBIO $54.60
- FICO $2,402.52
- Technical
- Relative Strength Index (RSI)
- BBIO 52.52
- FICO 58.97
- Support Level
- BBIO $49.94
- FICO $1,511.04
- Resistance Level
- BBIO $54.29
- FICO $1,598.00
- Average True Range (ATR)
- BBIO 2.14
- FICO 42.51
- MACD
- BBIO -0.28
- FICO 8.95
- Stochastic Oscillator
- BBIO 35.71
- FICO 73.07
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.